EA201100510A1 - EYE DROPS - Google Patents

EYE DROPS

Info

Publication number
EA201100510A1
EA201100510A1 EA201100510A EA201100510A EA201100510A1 EA 201100510 A1 EA201100510 A1 EA 201100510A1 EA 201100510 A EA201100510 A EA 201100510A EA 201100510 A EA201100510 A EA 201100510A EA 201100510 A1 EA201100510 A1 EA 201100510A1
Authority
EA
Eurasian Patent Office
Prior art keywords
eye drops
eye
trachoma
sulfonamides
chloramphenicol
Prior art date
Application number
EA201100510A
Other languages
Russian (ru)
Inventor
Виктор Владимирович Ни
Original Assignee
Товарищество С Ограниченной Ответственностью "Досфарм"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Товарищество С Ограниченной Ответственностью "Досфарм" filed Critical Товарищество С Ограниченной Ответственностью "Досфарм"
Publication of EA201100510A1 publication Critical patent/EA201100510A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к области медицины, в частности фармакологии. Капли глазные содержат активнодействующее вещество - хлорамфеникол, вспомогательные вещества - кислоту борную натрия и гидроксид, а также воду очищенную при следующем соотношении компонентов, мг/мл:Капли глазные проявляют лечебный эффект при воспалительных заболеваниях - конъюнктивитах, кератитах, блефаритах, блефароконъюнктивитах и кератоконъюнктивитах, при нейропаралитических кератитах при наличии вторичной бактериальной инфекции, при трахоме и др. Капли глазные могут быть использованы в случаях, когда у пациентов наблюдается непереносимость препаратов пенициллина, тетрациклина, сульфаниламидов или их применение при указанных глазных заболеваниях неэффективно.The invention relates to the field of medicine, in particular pharmacology. Eye drops contain active substance - chloramphenicol, excipients - boric acid sodium and hydroxide, as well as purified water in the following ratio of components, mg / ml: neuroparalytic keratitis in the presence of a secondary bacterial infection, with trachoma, etc. Eye drops can be used in cases when patients have the portability of penicillin, tetracycline, sulfonamides or their use in these eye diseases is ineffective.

EA201100510A 2010-11-15 2010-12-20 EYE DROPS EA201100510A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KZ20101409A KZ25018A4 (en) 2010-11-15 2010-11-15

Publications (1)

Publication Number Publication Date
EA201100510A1 true EA201100510A1 (en) 2012-05-30

Family

ID=46163585

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100510A EA201100510A1 (en) 2010-11-15 2010-12-20 EYE DROPS

Country Status (2)

Country Link
EA (1) EA201100510A1 (en)
KZ (1) KZ25018A4 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2473363C1 (en) * 2012-02-24 2013-01-27 Илья Александрович Марков Antiviral agent - eye drops
RU2485939C1 (en) * 2012-06-19 2013-06-27 Станислав Анатольевич Кедик Disulfiram and taurine-containing ophthalmological medication in form of eye drops
RU2688687C1 (en) * 2017-12-26 2019-05-22 Илья Александрович Марков Eye gel drops for treatment of inflammatory, virus, bacterial, allergic, metabolic, traumatic diseases
WO2021006856A1 (en) * 2019-07-11 2021-01-14 Людмыла Грыгоривна АЛМАКАЕВА Medicine in the form of eye drops

Also Published As

Publication number Publication date
KZ25018A4 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
EA201001413A1 (en) CONNECTIONS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS
EA201591027A1 (en) POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS
RS54438B1 (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
PH12014501718A1 (en) Novel therapeutic agents
FI3494972T3 (en) Combinations of dolutegravir and lamivudine for the treatment of hiv infection
EA201270824A1 (en) COMPOUNDS TO REDUCE BET-AMYLOID PRODUCTS
EA201290184A1 (en) BENZODIAZEPINUM INHIBITOR BROMODOMENE
EA201791019A1 (en) POLYCYCLIC CARBAMOILPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL APPLICATIONS
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
EA201291073A1 (en) DERIVATION CYPROMINE DERIVATIVES AS HYSTON INHIBITORS INHIBITORS LSD1 AND / OR LSD2
BR112013028813A2 (en) 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
EA201390626A1 (en) DERIVATIVES OF HYDROXAMIC ACID AND APPLICATION OF INDICATED DERIVATIVES IN THE TREATMENT OF BACTERIAL INFECTIONS
DE602007013391D1 (en) CYCLOSPORINS FOR THE TREATMENT AND PREVENTION OF EYE DISEASES
EA201300558A1 (en) CONNECTIONS AND METHODS FOR MORNING PAIN
EA201200918A1 (en) PYRROLIDIN DERIVATIVES OF CARBONIC ACID AS AN AGONISTS CONNECTED WITH G-PROTEIN RECEPTOR 43 (GPR43), PHARMACEUTICAL COMPOSITION AND METHODS OF THEIR USE IN THE TREATMENT OF METABOLICCHE
NZ607580A (en) N-heteroaryl compounds
AU2011208681A8 (en) Aqueous solution comprising 3 - quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
EP4327886A3 (en) Pyrimido- pyridazinone compounds and use thereof
EA201300132A1 (en) PHARMACEUTICAL COMPOSITION AND METHODS OF TREATMENT AND PREVENTION OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV
EA201100510A1 (en) EYE DROPS
EA201490045A1 (en) DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA
EA201201239A1 (en) A composition comprising as active ingredients L-CARNITINE IN COMBINATION WITH hydroxykynurenine-O-BETA-DL-glucoside FOR PREVENTING AND / OR TREATING PATHOLOGIES eyes caused by ultraviolet radiation
EA201490166A1 (en) Fluorinated arylalkyl-aminocarboxamide derivatives
RU2015112121A (en) MI-RNA AND THEIR APPLICATION IN METHODS AND COMPOSITIONS FOR TREATMENT AND / OR PREVENTION OF EYE CONDITIONS
EA201200086A1 (en) SUBSTITUTED 2-CARBOXAMIDES OF CYCLOAMINOM CEAMS